author-photo

Ingrid Louw

24

Papers

368

Citations

Citation Trend

Filter By

Papers (16) Sort By

Journal Conference Others

Open-Label Phase 3 Study of Intravenous Golimumab in Patients With Polyarticular Juvenile Idiopathic Arthritis.

2021 Rheumatology
Show All
- Source
- Cite
- Save
Citations (1)
Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis.

2021 The Journal of Rheumatology
Show All
- Source
- Cite
- Save
Citations (0)
THU0497 MAINTENANCE OF MINIMAL DISEASE ACTIVITY OR INACTIVE DISEASE STATUS AND PATIENT-REPORTED OUTCOMES IN INDIVIDUAL PAEDIATRIC PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH SUBCUTANEOUS ABATACEPT

2020 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Nurse-led care for the management of rheumatoid arthritis: a review of the global literature and proposed strategies for implementation in Africa and the Middle East.

2020 Rheumatology International
Show All
- Source
- Cite
- Save
Citations (3)
FRI0543 EFFICACY AND SAFETY OF INTRAVENOUS GOLIMUMAB IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM A PHASE 3 OPEN-LABEL STUDY

2019 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study

2018 Arthritis & Rheumatism
Show All
- Source
- Cite
- Save
Citations (29)
THU0549 Absence of association between drug exposure and infection in patients with polyarticular-course juvenile idiopathic arthritis and inadequate response to biologic or non-biologic dmards treated with sc and iv abatacept

2018 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
OP0058 Improvement in patient-reported outcomes in patients with polyarticular-course juvenile idiopathic arthritis and inadequate response to biologic or non-biologic disease-modifying antirheumatic drugs treated with sc abatacept

2017 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (1)
Abatacept sous-cutané chez des patients présentant une arthrite juvénile idiopathique polyarticulaire et une réponse inadéquate aux DMARDs conventionnels ou biologiques : pharmacocinétique, efficacité et sécurité

2017
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

2017 The Lancet
Show All
- Source
- Cite
- Save
Citations (207)